Jesús Siller Farfán

6PUBLICATIONS
38CO-AUTHORS
Molecular targetsHybrid and electric vehicles and powertrainsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Bioinformatic methods development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 04, 2024
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation.

Vanessa Mühlgrabner, Timo Peters, Rubí M-H Velasco Cárdenas

|Jan 04, 2023
Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors.

Jake Burton, Jesús A Siller-Farfán, Johannes Pettmann

|Oct 26, 2022
Current and future perspectives of chimeric antigen receptors against glioblastoma.

Josephine Zhang, Jesús A Siller-Farfán

|Jun 17, 2022
T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles.

Pablo F Céspedes, Ashwin Jainarayanan, Lola Fernández-Messina

|Sep 30, 2020
Developing a graduate training program in Synthetic Biology: SynBioCDT.

Idil Cazimoglu, Alexander P S Darlington, Aurelija Grigonyte

|Aug 22, 2018
Molecular mechanisms of T cell sensitivity to antigen.

Jesús A Siller-Farfán, Omer Dushek

Pageof 1